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Activation-induced deaminase (AID) provides 
the initial trigger for antibody gene diversifica-
tion, attacking deoxycytidine residues within 
the  immunoglobulin  locus  and  deaminating 
them to yield deoxyuridine. The resultant U:G 
mispairs are then recognized by components of 
both  base  excision  (uracil-DNA  glycosylase) 
and mismatch repair (MSH2–MSH6) pathways, 
leading to somatic hypermutation if the deami-
nation occurs within the IgV region, or class-
switch recombination if deamination is within 
the vicinity of the immunoglobulin S regions 
(Maul and Gearhart, 2010).
As an active DNA mutator, off-target ac-
tion by AID will predispose to genetic instabil-
ity; AID is indeed implicated in the causation of 
several B cell malignancies (Pérez-Durán et al., 
2007). There is therefore much interest in the 
mechanisms  that  control  the  level  of AID’s   
activity and that direct it toward its natural 
physiological  targets  in  the  immunoglobulin 
loci (Stavnezer, 2011). In fact, AID is largely 
found in the cytoplasm. Once imported into 
the  nucleus,  some AID  localizes  to  chromatin   
(including the immunoglobulin loci), where it 
has been preferentially detected at promoter-
proximal pause sites for RNA polymerase II 
at genes including (though not restricted to) the 
immunoglobulin  loci  (Yamane  et  al.,  2011). 
However,  much  of  the  AID  imported  into   
the  nucleus  is  likely  either  rapidly  exported 
back to the cytoplasm by virtue of its carboxy 
terminal nuclear export sequence (NES; Brar   
et al., 2004; Ito et al., 2004; McBride et al., 
2004) or degraded by the proteasome (Aoufouchi 
et al., 2008).
Nuclear AID is therefore subject to several 
possible alternative fates. It could be exported 
back to the cytoplasm, it could be degraded, 
or it could be targeted onto chromatin at ei-
ther the immunoglobulin loci (IgV or switch 
regions) or elsewhere. These differential fates 
of nuclear AID are presumably determined by 
differential interactions in which it partakes. 
In this paper, with a view to understanding 
these differential fates, we describe the results 
of a screen that we have performed to identify 
proteins interacting specifically with AID within 
the nucleus.
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Activation-induced deaminase (AID) acts on the immunoglobulin loci in activated B lympho-
cytes to initiate antibody gene diversification. The abundance of AID in the nucleus  
appears tightly regulated, with most nuclear AID being either degraded or exported back to 
the cytoplasm. To gain insight into the mechanisms regulating nuclear AID, we screened for 
proteins interacting specifically with it. We found that REG-, a protein implicated in 
ubiquitin- and ATP-independent protein degradation, interacts in high stoichiometry with 
overexpressed nuclear AID as well as with endogenous AID in B cells. REG- deficiency 
results in increased AID accumulation and increased immunoglobulin class switching.  
A stable stoichiometric AID–REG- complex can be recapitulated in co-transformed bacteria, 
and REG- accelerates proteasomal degradation of AID in in vitro assays. Thus, REG- 
interacts, likely directly, with nuclear AID and modulates the abundance of this antibody-
diversifying but potentially oncogenic enzyme.
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Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
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Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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The  purification  procedure  comprised  binding  Protein  G–
FLAG3-AID onto IgG-Sepharose, releasing the FLAG3-AID 
by cleavage with TEV protease and then purifying the FLAG3-
AID by absorption onto an anti-FLAG mAb matrix and   
elution with 3xFLAG peptide. After silver staining of a SDS- 
PAGE gel, the most striking difference between the nuclear 
and cytosolic AID samples was the presence, specifically in the 
nuclear sample, of a band of 31 kD which was of roughly the 
same intensity as the putative FLAG3-AID band itself (Fig. 1 C). 
Mass  spectrometric  analysis  confirmed  the  identity  of  the 
FLAG3-AID band and revealed the 31 kD band to be REG-, 
a nuclear protein (also known as PSME3, PA28 or 11S regu-
lator) implicated in a pathway of proteasome-dependent but 
ubiquitin- and ATP-independent protein degradation (Li and 
Rechsteiner, 2001; Zhou, 2006; Mao et al., 2008). Immuno-
fluorescence analysis confirmed that although the F193A-tagged 
AID mutant is substantially detected in the nucleus of trans-
fected Ramos cells, wild-type AID and REG- are largely 
found in different intracellular compartments in untransfected 
Ramos  cells  with  REG-  appearing  exclusively  nuclear, 
whereas AID is largely cytosolic (Fig. 1 B).
RESULTS AND DISCUSSION
REG- associates in high stoichiometry with overexpressed 
nuclear AID
To  facilitate  purification  of  AID-interacting  proteins,  we 
used a tagged AID derivative fused at its N terminus to two 
tandem protein G domains followed by a FLAG3 peptide, 
with the two protein G domains separated from the FLAG3 
peptide by a cleavage site for TEV protease (Fig. 1 A). Most 
AID in B cells is normally found in the cytoplasm. We there-
fore used a mutant (F193A), in which the phenylalanine resi-
due  within  AID’s  NES  had  been  substituted  by  alanine, 
allowing more of the protein to be retained within the nu-
cleus (Fig. 1 B; Geisberger et al., 2009). However, because 
increased nuclear expression of AID appears to be toxic, we 
incorporated an additional mutation, a glutamic acid→alanine 
substitution at AID’s active site (E58A), which destroys the 
enzyme’s catalytic activity but does not abolish its ability to 
coordinate zinc (Fig. S1 A).
Recombinant AID was purified from whole cell extracts of 
Ramos transfectants that expressed the tagged-nuclear or cyto-
solic AID (i.e., with or without the F193A NES mutation). 
Figure 1.  REG- co-purifies with tagged and endogenous AID. (A) Schematic depiction of Protein G–FLAG3-AID[E58A, F193A] indicating the Pro-
tein G (ProG) domains, TEV cleavage site, and FLAG3-tag epitope linked to a mutated AID, highlighting the Zn coordination motif and NES. (B) Localization 
in Ramos cells of transfected Protein G–FLAG3-AID[E58A] and Protein G–FLAG3-AID[E58A; F193A] (top two rows) and endogenous AID and endogenous 
REG- (bottom row). Proteins were detected as described in Materials and methods. Nuclei were stained with DAPI. Bars, 10 µm. (C) Silver-stained SDS-
PAGE gel of FLAG3-AID purified from Ramos cells transfected with either Protein G–FLAG3-AID[E58A] or Protein G–FLAG3-AID[E58A,F193A]. Parallel puri-
fications from Ramos cells transfected with Protein G–FLAG3-DNA polymerase  and untransfected Ramos cells served as controls. The Protein G–tagged 
proteins were purified by binding to IgG-Sepharose. After incubation with TEV protease, the eluted FLAG3-AID proteins were further purified by binding 
to anti-FLAG M2 agarose and eluted with 3xFLAG peptide. After SDS-PAGE and silver staining, mass spectrometric analysis confirmed the identity of the 
putative FLAG3-AID band (tryptic digested peptides YISDWDLDPGR; AWEGLHENSVR; ILLPLYEVDDLR) and revealed the asterisked band to be REG- (LDE-
CEEAFQGTK; SNQQLVDIIEK; MWVQLLIPR; NQYVTLHDMILK). Each lane on the SDS-PAGE gel contains the protein purified from 109 Ramos cells. The purifi-
cations were repeated in an independent experiment and gave similar results. (D) The presence of AID in anti–REG- immunoprecipitates (IP) from lysates 
of LMB (an inhibitor of Crm1-mediated nuclear export)-treated Ramos cells was analyzed by Western blotting with anti-AID antibody (EK2 5G9). An ali-
quot (0.4%) of total lysate was loaded as input and aliquots (0.4%) from each total lysate were also probed with anti–REG- and anti-AID antibodies. An 
independent experiment gave similar results. (E) Comparison of the abundance of AID in anti–REG- immunoprecipitates from different human B cell 
lines (Ramos, EL1BL, and Daudi) that had or had not been treated with 20 ng/ml LMB for 4 h before cell lysis. 293T cells served as a negative control. An 
aliquot (0.2%) of total Ramos lysate was loaded as input and aliquots (0.2%) from each total lysate were also probed with anti–REG- and anti-AID anti-
bodies. An independent experiment gave similar results.JEM Vol. 208, No. 12  2387
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indicating that REG- binds residues located within the 
N-terminal 60% of AID (Fig. 2 B). The binding of MBP-
AID to REG- appears to be of high affinity with the com-
plex,  remaining  stable  and  displaying  a  constant  ratio  of 
MBP-AID to REG- through further chromatographic pu-
rification (unpublished data).
REG- is a member of family of three structurally homolo-
gous proteins. REG- and REG- are interferon-inducible 
proteins that function in the cytoplasm, where they form a 
heteroheptamer which binds to the ends of the core 20S pro-
teasome catalytic machinery and is implicated in peptide gen-
eration during the MHC class I pathway of antigen processing 
(Rechsteiner et al., 2000; Sijts and Kloetzel, 2011). In con-
trast, REG- is nuclear and has been shown to bind a small 
number of intact proteins, including SRC-3 (steroid receptor 
co-activator 3; a transcriptional co-activator and oncogene; 
Li et al., 2006) and cell-cycle regulator p21 (a cyclin-dependent 
kinase inhibitor; Chen et al., 2007; Li et al., 2007). REG- 
has been implicated in their degradation by a pathway that is 
both ubiquitin and ATP independent. We found that whereas 
association is readily detected between MBP-AID and His6–
REG- coexpressed in E. coli, no similar association is seen 
when MBP-AID is coexpressed with REG- or REG- 
(Fig. 2 C).
Effects of REG- on AID abundance and turnover
REG- has been proposed to mediate the degradation of both 
SRC3 and p21 by binding them directly and escorting them 
to the proteasome (Li et al., 2006, 2007; Chen et al., 2007). 
To assess whether REG- could similarly assist the protea-
somal degradation of AID, we asked whether coexpression of 
REG- with tagged AID would lead to accelerated in vitro 
degradation by purified 20S proteasomes. The results revealed 
that, in the presence of the proteasome, REG- causes sub-
stantial destabilization of AID and that this destabilization is 
inhibited by the protease inhibitor MG132 (Fig. 3 A).
REG- is associated with endogenous nuclear AID
We were obviously concerned to ascertain whether endoge-
nous (as opposed to overexpressed and tagged) AID is also 
found to associate with endogenous REG-. Immunoprecip-
itation of REG- from Ramos cells does indeed bring down 
endogenous AID (Fig. 1 D). Furthermore, a larger amount of 
AID is brought down with immunoprecipitated REG- if 
the Ramos cells are pretreated with leptomycin B (LMB; an 
inhibitor of Crm1-mediated nuclear export) to increase the 
concentration of AID in the nucleus (Fig. 1 E). Similar obser-
vations were made with two other human B lymphoma lines, 
EL1BL and Daudi. Because Western blot analysis of separated 
cytosolic and nuclear fractions shows that 10% of the total 
AID in Ramos cells is associated with the nuclear fraction 
(unpublished data), we estimate that in the order of 5% of 
the nuclear AID in Ramos cells is brought down by immuno-
precipitation with anti-REG- antiserum.
Stable direct AID–REG- association can be recapitulated 
in bacteria
We suspected that the interaction between AID and REG- 
might be direct given that REG- was brought down in stoi-
chiometric amounts from the Ramos cell transfectants without 
evidence of other similarly dominant nuclear AID-associated 
bands (Fig. 1 C). We therefore asked whether we could re-
capitulate the AID–REG- association in bacteria. A fusion 
protein between AID and maltose-binding protein (MBP; 
MBP-AID) was coexpressed in E. coli with His-tagged REG-. 
Purification of the MBP-AID on an amylose column re-
vealed  that  the  MBP-AID  was  indeed  complexed  with   
His–REG-  (Fig.  2  A).  The  extracts  of  the  MBP-AID– 
expressing bacterial cells also contain a band migrating slightly 
faster than full-length MBP-AID. Mass spectrometric and 
N-terminal sequence analyses revealed that this band was 
caused by truncation of the MBP-AID at AID residue 116. 
This MBP-AID[116] truncation protein also binds REG-, 
Figure 2.  His6–REG- interacts directly with MBP-AID. (A) Lysates of MBP- or MBP-AID–expressing E. coli cells that had or had not been co- 
transformed with a plasmid directing expression of His6–REG- were analyzed by SDS-PAGE before (left four lanes) and after (right four lanes) pulldown by 
binding to amylose resin and elution with maltose. The gel (representative of three experiments) was stained with Coomassie blue. The asterisk indicates a 
truncation product of MBP-AID, which mass spectrometric analysis revealed to be a result of proteolytic cleavage at AID residue 116. (B) Both MBP-AID 
and MBP-AID[116] form a stable complex with REG-. MBPs from lysates of E. coli transformants coexpressing MBP-AID[116] and His6–REG- (as well as 
lysates from various control cells) were purified on amylose resin and/or Ni-NTA agarose as appropriate. The gel is representative of three experiments.  
(C) SDS-PAGE analysis of proteins pulled down on amylose resin from lysates of MBP-AID–expressing E. coli cells that had been co-transformed with 
plasmids encoding His6-tagged REG-, REG-, or REG- (right three lanes). Whole cell lysates before purification are shown for comparison (left three lanes).2388 Nuclear AID associates with REG- | Uchimura et al.
there must also be a REG-–independent pathway of de-
stabilization of nuclear AID. Indeed, enforced expression of 
AID[F193A] mutants in REG-–proficient and –deficient B 
cells revealed that the REG-–independent pathway for de-
grading overexpressed nuclear AID is dependent on AID’s 
lysine residues (Fig. 3 D), consistent with previous evidence 
of a ubiquitin-dependent pathway of AID turnover (Aoufouchi 
et al., 2008).
B cells from REG-–deficient mice give increased  
class switching
The efficiency of immunoglobulin class-switch recombina-
tion is highly sensitive to the precise abundance of AID. Thus, 
B cells from AID+/ heterozygous mice exhibit a twofold re-
duction in class switching (Sernández et al., 2008), whereas 
increased switching is evident in B cells in which AID expres-
sion is up-regulated by freeing it from micro-RNA regulation 
(de Yébenes et al., 2008; Dorsett et al., 2008; Teng et al., 
2008). We were therefore interested to find out whether the 
increased AID abundance evident in REG-–deficient mice 
correlates with increased class switching.
Culturing splenic B cells from REG-–deficient mice 
in the presence of IL-4+LPS revealed that they exhibited 
If REG- plays a role in the turnover of nuclear AID in 
normal B cells in vivo, one might expect an increased abun-
dance of AID in its absence. Two groups have described 
REG-–deficient mice and found that they display a very 
mild phenotype exhibiting a slight growth retardation in one 
study (Murata et al., 1999) and a small reduction in CD8 T cell 
numbers in the other (Barton et al., 2004). In most respects, 
however, the mice resembled their wild-type siblings. To as-
certain whether REG- deficiency affects AID abundance, 
we compared AID levels by Western blot analysis in whole 
cell  extracts  of  (IL4+LPS)-activated  splenic  B  cells  from 
REG-+/+, REG-+/, and REG-/ siblings generated by 
interbreeding of REG-+/ heterozygous mice. The results 
(Fig. 3 B) revealed that B cells from REG-/ animals had 
a significantly higher abundance of AID than their REG-–
proficient siblings.
Treatment of (IL-4+LPS)-activated B cells with LMB to 
inhibit AID nuclear export does indeed lead to AID destabi-
lization (Fig. 3 C). This destabilization of AID is somewhat 
less rapid in REG-–deficient B cells, supporting the pro-
posal that REG- plays a role in nuclear AID turnover in 
vivo. However, even in the absence of REG-, LMB treat-
ment  still  leads  to  rapid  AID  degradation,  indicating  that 
Figure 3.  REG- is implicated in AID degradation. (A) Lysates of E. coli cells that had been induced with IPTG to coexpress His6-AID together with 
REG- (left) or alone (right) were mixed with 20S proteasomes and incubated with 37°C for the indicated times before subjecting to SDS-PAGE. The blots 
were then probed with anti-AID (EK2 5G9), anti–REG-, and anti-20S proteasome antibodies (top). A graph below summarizes the results of two inde-
pendent such experiments along with controls showing the effects of the inclusion of a proteasome inhibitor (MG132; closed circle) or omission of the 
20S proteasome (w/o 20S; open square). Error bars indicate mean ± SEM. (B) 100-µg extracts of purified splenic B cells from REG-+/+, REG-+/, and 
REG-/ siblings that had been activated for 3 d with IL-4 and LPS were subjected to SDS-PAGE and probed after blotting with anti–mouse AID (mAb 
94.16), anti–REG-, and anti–-tubulin (tub) antibodies. Two independent experiments (#1 and 2) are shown in the top, with the results of four indepen-
dent experiments comparing AID protein abundance in B cells from REG-–deficient mice relative to littermates presented in the histogram below. The 
strengths of the AID bands have been quantified with ImageJ (National Institutes of Health) and normalized with respect to -tubulin. Error bars indicate 
mean ± SEM. (C) Purified splenic B cells from REG-+/ and REG-/ siblings were activated for 3 d with IL-4 and LPS and then cultured with 20 ng/ml 
LMB for 2.5, 5, and 7.5 h. 100 µg LMB-treated extracts was loaded onto SDS-PAGE gels and blots probed with anti–mouse AID, anti–REG-, and anti–-
tubulin antibodies (top). Relative AID protein level was quantified with ImageJ and normalized with respect to -tubulin in each time point. To compare 
the reduction of AID protein between two genotypes, the level of AID protein at time zero was set to 100%. Pooled data from four independent experi-
ments are plotted below. Error bars indicate mean ± SEM. (D) C-terminally HA-tagged AID[F193A] and two derivatives (KR1 and KR2) in which all eight 
AID lysine residues had been mutated to arginine (the two derivatives differ in assigned codon usage) were expressed in splenic B cells from REG-+/+ and 
REG-/ mice by retroviral transduction using pMX-IRES-GFP vector. The abundance of AID-HA and GFP in the whole cell extracts 2 d after transduc-
tion was monitored by Western blotting (top). The graph below summarizes the results of two independent experiments (all AID mutants analyzed carry 
the F193A mutation). Error bars indicate mean ± SEM.JEM Vol. 208, No. 12  2389
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substantially higher proportion of IgG1+ cells compared with 
the REG-–proficient controls as analyzed at each cell divi-
sion (Fig. 4 B). Furthermore, flow cytometric comparison of 
bone marrow and spleen samples from REG-/ and con-
trol siblings did not reveal any changes in B cell develop-
ment, although it confirmed the previously noted (Barton 
et al., 2004) very small reduction in the proportion of CD8+ 
single positive splenic T cells (Fig. S2 C).
Reduced AID degradation in REG-/ mice might also 
be expected to lead to a more general increase in genomic 
instability. However, REG-/ mice on a normal back-
ground do not show any marked increase in tumor incidence, 
possibly reflecting p53 and other checkpoints (Jankovic et al., 
2010). Only a small increase in the frequency of c-myc–IgH 
translocations was detected in cultured B cells from REG-–
deficient (as opposed to REG-–proficient) mice in which 
AID overexpression had been induced by retroviral transduc-
tion (Fig. S3), possibly reflecting the ubiquitin-dependent 
degradation of such overexpressed AID (Fig. 3 D). Thus, 
although the results suggest that the dramatically increased 
class-switching in REG-–deficient mice is likely to be at 
least in part a direct consequence of the increased AID abun-
dance, we cannot exclude the possibility that there is an ad-
ditional contribution from some as yet unidentified effect of 
REG- deficiency (e.g., a perturbation of AID’s interaction 
with other nuclear partners).
These results identify AID as a novel target of REG- 
regulation. A feature shared by AID with most cellular REG- 
targets identified so far (SRC3, p21, and MDM2-p53; Li 
et al., 2006, 2007; Chen et al., 2007; Zhang and Zhang, 2008) 
is that misexpression of these nuclear proteins is potentially 
oncogenic.  With  AID,  as  with  the  other  REG-  targets, 
REG- contributes to its nuclear degradation but clearly does 
not provide the sole route to its regulated turnover. Never-
theless, the phenotype of B cells from REG-–deficient mice 
suggests that, under normal conditions, REG- might well 
provide a major pathway of nuclear AID destruction, with 
other pathways taking over in its absence. It is also possible 
that the ubiquitin- and ATP-independent REG- pathway 
might prove of especial importance under certain conditions, 
for example in cells with low concentrations of ATP.
Our results show that 5% of the endogenous nuclear 
AID in Ramos B cells (as well as a substantially higher pro-
portion  of  overexpressed  mutant  AID)  is  associated  with 
REG-. Although the structural basis is at present unclear, 
the bacterial coexpression assays indicate that this interaction 
is likely direct. We suspect that part of the AID surface might 
exhibit a naturally unfolded conformation that can fold to 
adopt a structure, which facilitates interaction with REG- 
or other suitable partners. Indeed, a role for such naturally 
unfolded segments in REG-’s clients has already been pro-
posed to account for the ability of REG- to mediate the 
proteasomal degradation of these clients without requirement 
of ATP (Li and Rechsteiner, 2001; Zhou, 2006). In which 
case, the ability to interact with REG- in vitro might extend to 
other members of the AID/APOBEC family. We therefore 
substantially increased class switching as compared with their 
littermate controls in each of six independent comparisons; 
the mean percentage of IgG1+ cells at day 3 of culture in-
creased  from  19.6%  in  REG-+/  heterozygous  mice  to 
28.1% in REG-–deficient siblings (Fig. 4 A). On average, 
the REG-–deficient B cells gave 40% more switching on 
day 3 as compared with their litter-matched controls. How-
ever, deficiency in REG- does not lead to any detectable 
change in the abundance of 1-sterile transcripts (Fig. S2 A). 
Extending the analysis of switching to a further seven sets of 
litter-matched siblings revealed that although deficiency in 
REG- does not lead to any detectable change in the rate of 
B cell proliferation, the REG-–deficient B cells exhibited a 
Figure 4.  Increased class-switch recombination in B cells from 
REG-–deficient mice. (A) Flow cytometric analysis of class switching in 
(IL-4+LPS)-activated splenic B cells from REG-+/+, REG-+/, and REG-
/ mice. After 3 d of activation, purified splenic B cells were stained 
with PE-conjugated anti-B220 and biotinylated anti-IgG1, followed by 
APC-conjugated streptavidin. FACS profiles from two pairs of REG-+/ 
and REG-/ littermates are shown on the left. A graph on the right 
summarizes the results from six sets of littermates (error bars indicate 
mean ± SEM). The p-values were calculated using the unpaired two-tailed 
Student’s t test. (B) Purified splenic B cells from REG-+/ and REG-/ 
mice were labeled with CFSE and stimulated with IL-4 and LPS. After 3 d 
of activation, the B cells were stained for B220 and IgG1. The graph on 
the top shows the distribution of the total B cell population on day 3 
according to the extent of division they have undergone during culture 
and the graph below shows the percentage of B cells that have switched 
to IgG1 at day 3 as a function of the number of cell divisions undergone. 
A total of seven litter-matched pairs of mice in three independent experi-
ments were analyzed. Error bars indicate mean ± SEM. Representative 
examples of the primary analyses are shown in Fig. S2 B.2390 Nuclear AID associates with REG- | Uchimura et al.
with DAPI-containing mounting medium (VECTASHIELD; Vector Labo-
ratories) and observed using a Radiance 2100 confocal microscope (Bio-Rad 
Laboratories) with a Plan Apo 60×/1.40 NA oil immersion lens (Nikon)   
using LaserSharp 2000 acquisition software (Bio-Rad Laboratories).
Immunoprecipitation and Western blot analysis. For analysis of en-
dogenous AID in B cell lines, cells (which had, if required, been preincu-
bated with 20 ng/ml LMB [LC Laboratories] for 4 h at 37°C) were lysed in 
buffer A supplemented with 0.4 mg/ml lysolecithin, 50 µg/ml RNase A, 
150 U/ml benzonase (Novagen), and protease inhibitor cocktail. Clarified 
lysates were mixed with anti–REG- antibody at 4°C for 30 min and incu-
bated with Protein A–Sepharose (GE Healthcare) at 4°C for 30 min. Beads 
were then washed with buffer A and subjected to SDS-PAGE.
For analysis of endogenous AID in mouse splenic B cells, clarified lysates 
prepared from cells lysed by 30 min of incubation on ice in 10 mM Hepes, 
pH 7.9, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate, 
150 U/ml benzonase, 0.1 mM PMSF, and protease inhibitor cocktail were 
subjected to SDS-PAGE (100 µg/lane). Protein concentration in lysates was 
measured with a BCA protein assay kit (Thermo Fisher Scientific). Human 
AID and REG- were detected in Western blots using the same antibodies 
used for immunofluorescence, whereas mouse AID was detected with mAb 
94.16 (provided by Hans-Martin Jäck, Erlangen, Germany) and -tubulin is 
a rabbit antiserum (Abcam). Mutant AIDs containing a C-terminal HA tag 
were expressed in mouse splenic B cells by retroviral transduction using 
pMX-IRES-GFP vector as previously described (Geisberger et al., 2009).
Class-switching assays. REG-–deficient mice that had been bred onto a 
C57BL/6 background (Barton et al., 2004) were bred in our animal facility 
under UK Home Office project license PPL80/2226 against C57BL/6 mice. 
Heterozygous  animals  were  used  to  produce  age-matched  littermates  of   
8–12 wk for class-switching assays. Splenic B cells that had been enriched by 
depletion of CD43+ cells using anti-CD43–coupled magnetic beads (Miltenyi 
Biotec) were seeded in 24-well plates (0.5 × 106 per well) in 1 ml RPMI 
supplemented with 10% FBS, 0.05 mM 2-mercaptoethanol, 25 ng/ml recom-
binant mouse IL-4 (R&D Systems), and 40 µg/ml LPS (Sigma-Aldrich). On 
day 3 of stimulation, B cells were stained with PE-conjugated anti-B220 and 
biotinylated anti-IgG1 (followed by APC-conjugated streptavidin; all from 
BD). Flow cytometry was performed using an LSRII (BD), excluding dead 
cells with propidium iodide and analyzing switching data with FlowJo software 
(Tree Star). For cell division analysis, isolated splenic B cells were stained with 
5 mM CFSE (Invitrogen) and stimulated with IL-4 and LPS as described.
Assaying AID–REG- association in bacteria. E. coli BL21(DE3) cells 
that had been transformed with AID/APOBEC cDNAs cloned into pMAL-
c2X  vector  (NEB)  and/or  N-terminally  hexa-His–tagged  REG-//  
cDNAs cloned into the p15A origin–containing vector pACYC-T7 (Yasukawa 
et al., 1995) were induced with 0.3 mM IPTG at 20°C for 16 h. Bacterial 
pellets were sonicated in buffer B (10 mM Hepes, pH 7.9, 200 mM KCl, 
0.1% Triton X-100, and 1 mM DTT) containing 10 µg/ml DNaseI, 10 µg/ml 
RNaseA, 1 mM PMSF, and protease inhibitor cocktail. Maltose binding 
proteins were purified from the clarified lysates by binding for 1 h at 4°C on 
to amylose resin (NEB) and eluted from the washed beads with 50 mM 
maltose in buffer B.
Assaying proteasomal degradation in vitro. E. coli BL21(DE3) was co-
transformed  with  pET30  (Novagen)-His6-AID  and  either  pACYC-T7–
REG- or unmodified pACYC-T7 control plasmid. Cells were induced 
with 0.3 mM IPTG at 20°C for 16 h. Bacterial pellets were then sonicated 
in 50 mM Hepes, pH 7.9, 150 mM NaCl, 10% glycerol, 0.5 mM EDTA, 
and 1 mM DTT, and clarified lysates were incubated with 140 nM 20S pro-
teasomes (BostonBiochem) at 37°C for the indicated times. MG132 (Sigma-
Aldrich), where required, was included at 10 µM.
Online supplemental material. Fig. S1 shows that the E58A and trun-
cation mutants of AID retain the ability to coordinate zinc and that, after 
performed  additional  bacterial  pulldown  experiments  and 
found that, although REG- exhibits preferential binding   
to AID, lesser binding is also obtained with APOBEC1 and 
APOBEC3 when coexpressed in Escherichia coli but not with 
APOBEC2 or substantial amounts of endogenous bacterial 
proteins (Fig. S1 B). We have been unable to reconstitute   
the REG- interaction with fully denatured MBP-AID, but 
REG- recognition of AID does not require the intactness   
of AID’s Zn-binding motif (Fig. S1 C), although we do not 
know  the  effect  on  AID  folding  of  the  loss  of  critical   
zinc-coordinating residues. The results are therefore consis-
tent with a model in which AID presents a naturally unfolded 
face (which might contribute to the stickiness and aggregation 
of the protein as analyzed in vitro) that could also form part 
of the site of interaction of AID with several of its bona fide 
cytoplasmic and nuclear partners. Indeed, the role of REG- 
could be to scavenge unattached AID for degradation in situ-
ations when it has been jettisoned by one of its nuclear part-
ners. Alternatively, in view of the apparent high affinity of 
the AID–REG- interaction, REG- might serve to actually 
limit the availability of AID to its physiological or even 
nonphysiological interactors. Insight into these possibilities 
might be provided by elucidating the structural basis of the 
AID–REG- interaction, comparing to the interactions that 
AID displays with other bona fide partners.
MATERIALS AND METHODS
Cell lines. Human AID[E58A], AID[E58A; F193A], and DNA polymerase  
cDNAs were cloned into plasmid pEAK8-ProteinG-FLAG3. The pEAK8 plas-
mid was obtained from Edge BioSystems. Protein G–FLAG3 is a tag comprising 
two tandem Protein G domains (Bürckstümmer et al., 2006) and a FLAG3 epi-
tope separated by a TEV cleavage site. These plasmids were transfected into   
Ramos cells by electroporation. Stably transfected colonies were picked up after 
2 wk of selection with puromycin and expanded in RPMI supplemented with 
10% FBS, 0.05 mM 2-mercaptoethanol, and 0.3 µg/ml puromycin.
Purification and mass spectrometric analysis of tagged AID from 
Ramos cells. Transfected Ramos clones (109 cells) were lysed in 10 ml buf-
fer A (20 mM Hepes, pH 7.9, 10% glycerol, 150 mM NaCl, 2.5 mM MgCl2, 
10 µM ZnCl2, 0.2% Triton X-100, 2 mM DTT, and 2 mM N-ethyl-
maleimide) supplemented with 0.4 mg/ml lysolecithin, 50 µg/ml RNase A, 
and protease inhibitor cocktail (Roche). Clarified lysates were incubated 
with 150 µl rabbit IgG-Sepharose 6FF (GE Healthcare) at 4°C for 1 h. The 
IgG-Sepharose beads were washed with buffer A and incubated with 40 U 
AcTEV protease (Invitrogen) at 4°C overnight. The protein released as a re-
sult of TEV cleavage was incubated with 25 µl anti-FLAG M2-agarose 
(Sigma-Aldrich) at 4°C for 1 h and eluted with 30 µl 3xFLAG peptide   
(0.15 µg/µl; Sigma-Aldrich). The samples eluted with 3xFLAG peptide were 
then subjected to SDS-PAGE and stained with a SilverQuest staining kit 
(Invitrogen). The indicated bands were excised for tryptic digestion. Mass 
spectrometric analysis was performed with HCT Ultra II with electron transfer 
dissociation (Bruker Daltonics). Spectra were analyzed with Scaffold 2 pro-
teome software (Proteome Software Inc.).
Immunofluorescence analysis. Cells were fixed with 4% paraformalde-
hyde and permeabilized with 0.2% Triton X-100. Untransfected Ramos cells 
were stained with rat anti-AID mAb (EK2 5G9; Cell Signaling Technology), 
followed by anti–rat IgG-488 (Invitrogen) and rabbit anti–REG- (Biomol), 
followed  by  anti-rabbit  IgG-568  (Invitrogen).  Protein  G–FLAG3  stable 
transfectants were stained with goat anti–rabbit IgG-FITC (Southern Bio-
tech; to detect Protein G–containing fusion proteins). Samples were mounted JEM Vol. 208, No. 12  2391
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coexpression in E. coli as MBP fusion proteins, MBP-AID binds REG- 
more strongly than do various MBP-APOBEC chimeras. Fig. S2 compares   
the abundance of various lymphoid subpopulations, the amount of (IL-4+LPS)-
induced sterile 1 transcripts, and the degree of switching to IgG1 in   
REG-/ and REG-+/ mice. Fig. S3 compares c-myc-IgH transloca-
tions in (IL-4+LPS)-activated splenic B cells from REG-/ and REG-+/  
mice. Online supplemental material is available at http://www.jem.org/cgi/ 
content/full/jem.20110856/DC1.
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